INTRODUCTION
risk, resource utilization, as well as costs of medical care (Pereira, Weiner, Scott, T., & Sarnak, 2005 ; Tarter & Switala, 2000 ) . Importantly, however, cognitive problems in patients with CKD may also independently result from comorbid conditions like cardiovascular disease and diabetes (KorenMorag, Goldbourt, & Tanne, 2006 ; Sarnak & Levey, 2000 ) , especially since diabetes mellitus and hypertension are still among the most frequent underlying risk factors for CKD (Levey et al., 2009 ; Rutkowski & Król, 2008 ) .
Among all patients with CKD, the prevalence of cognitive defi cits is particularly high in subjects with ESRD (see Pliskin, Kiolbasa, Hart, & Umans, 2001 ). The most frequently reported cognitive problems in this population include memory defi cits, reduced mental effi ciency, decreased psychomotor speed, as well as impaired attention (e.g., Altmann, Barnett, Finn, & Lanthanum Carbonate Study Group, 2007 ; Harciarek, Biedunkiewicz, LichodziejewskaNiemierko, D ę bska-Ś lizie ń , & Rutkowski, 2006 ; Kurella et al., 2004 ) . Furthermore, although dialysis may reduce neuropsychological defi cits associated with ESRD (Hart, Pederson, Czerwinski, & Adams, 1983 ; Pliskin, Yurk, Ho, & Umans, 1996 , Umans, & Pliskin, 1998 Ryan, Souheaver, & DeWolfe, 1981 ; Teschan et al., 1979 ) , a majority of recent studies have shown that cognitive impairment persists even in adequately dialyzed patients (Evans, Wagner, & Welch, 2004 ; Murray et al., 2006 ; Vos et al., 2006 ; Wolcott et al., 1988 ) . Additionally, the dialysis process itself may directly contribute to a new brain pathology and, thus, can add to already existing neuropsychological defi cits, possibly by inducing cerebral ischemia or cerebral edema through intravascular volume loss, as well as fl uid shifts (Altmann et al., 2007 ; Griva et al., 2003 ; Kamata et al., 2000 ) . Therefore, despite a well-documented role of dialysis as a kidney replacement therapy, its ability to decrease cognitive impairment in patients with ESRD may be relatively limited.
Instead, it has been suggested that a successful kidney transplant may signifi cantly improve cognitive abilities of patients with ESRD and that the magnitude of this improvement is much greater than that associated with the use of dialysis. Nevertheless, evidence supporting these hypotheses comes almost entirely from studies of pediatric transplant populations (e.g., Mendley & Zelko , 1999 ) , because only a few attempts to evaluate the effects of kidney transplant on cognition in adults have been made (Griva et al., 2004 (Griva et al., , 2006 Kramer et al., 1996 ; Teschan, Ginn, Bourne, & Ward, 1976 ; Teschen et al., 1979 ) . Moreover, studies of adults with kidney transplants have not always provided consistent evidence regarding cognitive function after graft surgery. For example, Kramer and colleagues (1996) demonstrated that kidney transplant may improve the performance on measures of psychomotor speed, such as the Trail Making Test A. Alternatively, Griva and coworkers (2006) reported a significant improvement only in memory function, whereas Gelb, Shapiro, Hill, & Thornton ( 2008) showed that cognition following kidney transplantation may be similar to that observed in persons with CKD, and worse than in healthy controls. Most of these fi ndings come from cross-sectional comparisons, however. Other methodological limitations include small sample sizes and insuffi cient control of demographics, as well as comorbid conditions associated with ESRD and dialysis. Additionally, in the few prospective studies that have been reported, there was often a large variation in the timing of post-transplantation cognitive testing. Furthermore, some studies did not include a comprehensive assessment of all cognitive domains or well-matched controls to control for learning effects associated with repeated administration of neuropsychological measures. Thus, defi nite conclusions regarding the potentially benefi cial effect of kidney transplantation on cognition in adults with ESRD are diffi cult to draw. This is an important issue, however, because cognitive limitations may signifi cantly affect the adherence to complex post-transplant medication regimens. Also, determining the infl uence of kidney transplantation on neuropsychological performance may help to better understand the etiology of intellectual diffi culties in ESRD. For example, if cognitive impairment in subjects with ESRD is related to the accumulation of toxins and dialysis-specifi c factors, it could be expected that it would improve shortly after successful kidney transplantation. Alternatively, if cognitive defi cits in this population are predominantly caused by ESRD comorbid conditions (e.g., cardiovascular disease), it is unlikely that they recover following transplantation. Additionally, it is unknown whether some demographic and/or medical factors (e.g., time spent on dialysis) can be potentially associated with the degree of the neuropsychological improvement after kidney transplant surgery. Therefore, the main purpose of this study is to prospectively assess and characterize the cognitive performance of adequately dialyzed patients with ESRD before and after kidney transplantation, as well as to determine what pre-, intra-, and postoperative factors may be related to the extent of a presumptive change in cognitive performance after kidney transplant.
METHODS

Participants
Twenty-two dialyzed patients with ESRD who subsequently received kidney transplant (TX), 20 dialyzed patients with ESRD who were medically qualifi ed and awaiting kidney transplant but, because of a lack of an appropriate donor, did not receive it (NTX), and 30 matched controls (MC) were the participants for this study. The detailed demographic and clinical characteristics of these three groups are presented in Table 1 . Additionally, specifi c clinical and medical measures at baseline associated with ESRD (primary kidney disease diagnosis, duration of CKD, time spent on dialysis, type of dialysis, blood urea nitrogen (BUN), creatinine, hemoglobin, albumin, dialysis adequacy as assessed by a calculated kinetic transfer/volume urea measurement (Kt/V)) are also described. Importantly, Kt/V was calculated for patients on hemodialysis (HD) (single pool Daugirdas formula), performed 3 times a week, and subjects on peritoneal dialysis (PD) (total weekly Kt/V urea), separately. Also, only measurements of adequacy obtained within 1 month from the assessment were included in the analyses. Blood samples for biochemical data of patients with ESRD were always obtained shortly after completion of cognitive assessment, thus, the venopuncture pain did not interfere with the neuropsychological performance.
Eligible participants were enrolled if they were between 21 and 65 years of age, had no malignancies or clinically evident cerebrovascular disease as refl ected by neurological defi cits, had no uncontrolled hypertension, diabetes and/or anemia, mental retardation, psychiatric disorders, psychoactive drug treatment (e.g., benzodiazepines), dementia, or alcohol abuse. Additionally, subjects who had clinically relevant visual or hearing diffi culties, as well as other major organ failure (e.g., end-stage liver disease), were not included. The fulfi llment of these criteria was determined by interviewing both participants and their relatives, as well as by reviewing participants' medical records. All subjects underwent a complete neurological and cardiological evaluation. Also, during baseline testing, all patients with ESRD had estimated GFR < 15 ml/min/1.73m 2 (stage 5 of chronic kidney disease), calculated with the widely used 4-variable equation (Levey et al., 1999 ) , and had received at least 1 year of dialysis. All 42 participants with ESRD were from a regional waitlist of 47 dialyzed patients awaiting kidney transplant; 5 remaining patients were not included, because they were either on psychoactive medications or received a kidney transplant shortly after being enrolled in the transplantation waitlist, so that the cognitive assessment could not be conducted. Patients with ESRD were recruited from the Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gda ń sk, from January 2005 to December 2007. All MC individuals, with no history of nephrological problems (mean GFR = 116.18 ml/min/1.73m 2 ; SD = 10.70), were citizens of Gda ń sk and were subjected to the same exclusion criteria as patients with ESRD. Importantly, to control for hypertension and diabetes, 16 MCs were recruited from the Outpatient Hypertension and Diabetology Clinic, Medical University of Gda ń sk.
None of the participants was ill or hospitalized at the time of the assessment. Subjects treated for diabetes and/or hypertension at baseline were still on their antidiabetic and/or antihypertensive medications at the follow-up testing. All individuals were right-handed and native Polish speakers. Before testing, informed consent was obtained from each study participant. Patients from the TX group received a kidney transplant within 10 months from the baseline testing (range: 202 to 297 days). In all of these cases, it was a cadaver transplant. Following kidney transplantation, the renal function in all graft recipients was adequate (mean GFR = 53.22 ml/ min/1.73m 2 ; SD 18.46). All kidney recipients were treated with immunosuppressive drug therapy: cyclosporine or tacrolimus, mycophenolate mofetil or mycophenolate sodium, and steroids. Subsequent to transplantation, 2 TX patients developed diabetes and 1 developed hypertension. Thus, they were additionally treated with antidiabetic or antihypertensive agents.
Neuropsychological assessment
The neuropsychological tests used in this study were selected on the basis of their sensitivity, acceptance, and extensive use in renal populations (see Pliskin et al., 2001 ) . To assess the general cognitive status of patients with ESRD, the Mini-Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975 ) was used.
Acquisition and recall of verbal material were assessed with a Polish standardized version of the Rey Auditory Verbal Learning Test (RAVLT) (Choynowski & Kostro, 1980 ) . A list of 15 concrete nouns was presented orally 5 times in succession. Subjects attempted to recall orally as many words as they could remember at the end of each trial. Following the 5 learning trials, a delayed recall trial was given 25 minutes later, and a recognition test was given immediately after the delayed trial. For the recognition trial, 15 target words and 15 frequency-matched distractor words were presented orally one at a time, and subjects were asked to indicate whether or not each word was from the study list. The variables of interest were recalled words summed across all 5 learning trials (total learning), words recalled after a delayed interval ( delayed recall), as well as words correctly recognized.
Visual learning was assessed with Brief Visual Memory Test-Revised (BVMT-R) (Benedict, 1997 ) . For BVMT-R, the stimulus material is a matrix of 6 visual designs, shown to the participant for 10 seconds. Subjects are asked to draw the designs using paper and pencil. Each design receives a score of 0, 1, or 2, based on accuracy and location scoring criteria. There are 3 free-recall trials preceded by stimulus exposure. Similarly to RAVLT, there is a 25-minute interval following the fi nal learning trial, after which delayed recall and recognition trials are performed.
Additionally, visuo-spatial memory, construction, and organization ability was assessed with Rey-Osterrieth Complex Figure test (RCF) (Lezak, 2004 ; Strupczewska, 1990 ) . Participants were asked to copy and recall (after 3-4-min interval) a complex geometric fi gure consisting of 18 defi ned elements. In this study, variables of interest were overall accuracy scores (range 0-36), counted separately for a copy and a recall.
Attention and working memory was assessed using the Digit Span subtest of the Polish adaptation of the Wechsler Adult Intelligence Scale -Revised (WAIS-R-PL) forwards and backwards, respectively (Brzezi ń ski, Gaul, Hornowska, Machowski, & Zakrzewska 1996 ) . The Digit Symbol subtest of the WAIS-R-PL, and the Trail Making Test (TMT; Part A and B) derived from the Polish adaptation of the HalsteadReitan Neuropsychological Test Battery (H-RNTB) (K ą dzielawa, Mroziak, Bolewska, & Osiejuk, 1990 ) were used to measure visuo-mental processing and psychomotor speed. For the TMT (Part A and B), the score was the number of seconds needed to complete the task; the higher the score, the slower, more impaired the performance. Motor abilities were additionally assessed with the Finger Tapping Test from H-RNTB. The Similarities subtest of the WAIS-R-PL was used to evaluate the ability to generalize and form verbal concepts, as well as abstract thinking. For all these measures, raw scores were calculated according to the standardized procedures for each test that was used to conduct the analysis.
Phonemic and semantic verbal fl uency was also assessed. Based on previous works (e.g., Jodzio, 2006 ) , we have used the letter "K" for phonemic fl uency and names of animals for semantic (category) fl uency. The letter "K" was chosen because in Polish, words beginning with this letter have a relatively high frequency of usage, similar to that of the letter "F" in English (see Lezak, 2004 ) . The dependent variables were total number of words generated in 60 seconds for each fl uency task. Supplementary to semantic fl uency, semantic knowledge was additionally measured by the Vocabulary subscale of the WAIS-R-PL (Brzezi ń ski et al., 1996 ) .
Depressive and anxiety symptoms were measured by a Polish adaptation of Zigmond and Snaith's Hospital Anxiety and Depression Scale (HAD) (Majkowicz, 1994 ) . This questionnaire consists of 14 items: 7 questions refer to anxiety and the remaining 7 items assess depression, with the summed score of each subscale indicating the severity of anxiety and/ or depression.
Procedure
The cognitive performance in all three groups was assessed twice, with the follow-up testing approximately 256 days (8.5 months) from baseline (mean = 256.29; SD = 22.89). In the TX group the mean time between the date of kidney transplantation and the follow-up testing was 30 days ( SD = 25.22). Importantly, for all TXs, the follow-up assessment took place shortly after patients were discharged and when none of them presented with any post-operative complications: mean BUN = 31.32 ( SD = 14.97), mean creatinine = 1.68 ( SD = .61), mean albumin = 4.21 ( SD = .19), mean hemoglobin = 11.97 ( SD = 1.13).
Subjects from all groups were tested in the same standardized way and the neuropsychological measures were given in the same order to all 72 participants. Additionally, each subject was evaluated at the same time of the day (+/-3 hours) to control for variations in performance caused by possible diurnal effects. Because of temporal fl uctuations in cognitive performance in patients on HD (see Griva et al., 2003 ) , they were tested approximately 24 hr after receiving the last HD. All participants were examined in the same, specially designated room.
We acknowledge that all data included in this was article were obtained in compliance with regulations of our institutions, and human research was completed in accordance with the guidelines of the Helsinki Declaration ( http :// www . wma . net / e / policy / 17 -c_e . html ).
Statistical analysis
All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS version 14 for Windows) and all the differences were tested at an alpha level of .05 (2-tailed).
A series of one-way analysis of variance (ANOVA) (for continuous data) and chi-square ( ␣ χ␣ 2 ) tests (for categorical data) were performed to compare all three groups (TX vs. NTX vs. MC) on demographics and selected clinical measures. In addition, clinical and biochemical factors specifi c only for groups with ESRD were compared using t tests for independent samples or ␣ χ␣ 2 tests (for categorical variables).
Comparisons of raw cognitive, as well as depressive and anxiety, scores of all three groups between baseline and the follow-up assessment were performed using (2 ␣ ×␣ 3) ANOVAs with repeated measures, with the within-subject factor being time of testing (baseline vs. follow-up), and the betweensubject factor being group (TX vs. NTX vs. MC). The dependent variable was a mean score obtained in each cognitive measure. Post-hoc comparisons of between-group effects were conducted using a Tukey's test and the dependent t test was used for within-group comparisons. Estimates of Cohen's d in pairwise comparisons were calculated using dependent t -test values, n (paired), and correlations for paired values (see Lipsey & Wilson, 2001 ), whereas effect sizes in ANOVA (partial eta-squared) were computed using the procedure implemented in SPSS.
To determine whether some baseline, intra-and/or postoperative factors may be associated with the extent of change in cognitive performance pre-to post-transplantation, an index of improvement (IOI) for each cognitive task in which TXs' performance changed signifi cantly over time (see Table 2 ) was created. The IOI was calculated using the following formula: (raw score follow up -raw score baseline ) / raw score baseline . An exception was the TMT in which scores refl ect time needed to complete the task. Overall, the higher the IOI value, the more improved the performance. Next, Spearman rank order correlation analyses were performed between each IOI and 18 selected baseline (age, sex, education, illness duration, type of dialysis, time on dialysis, BUN, creatinine, Kt/V, hemoglobin, albumin, hypertension, diabetes, depression, anxiety), intraoperative (duration of cold and warm organ ischemia), as well as postoperative (GFR), factors.
RESULTS
Demographics, clinical, and biochemical factors
There were no statistically signifi cant group differences in demographics, as well as anxiety and depression, at baseline (see Table 1 ). Additionally, groups did not differ signifi cantly from each other in number of subjects with hypertension, diabetes, hepatitis C, heart conditions, and coronary artery bypass grafting. Also, the comparison of factors specifi c for the kidney population did not show any group differences in the duration of CKD, type of dialysis, time on dialysis, BUN, creatinine, Kt/V, albumin, hemoglobin, and recombinant human erythropoietin (rHuEPO) treatment. Importantly, there was also no statistically signifi cant group difference in time between baseline and the follow-up assessment.
Prospective cognitive assessment
As expected, a number of statistically signifi cant main effects and interactions were found (see Table 2 and Fig. 1 ). For the RAVLT total learning score, a main effect of group ( F = 5.13; p < .01; η p 2 = .13) and a signifi cant interaction ( F = 3.23; p < .05; η p 2 = .09) emerged. Regardless of the assessment (baseline vs. follow-up), NTX patients had lower scores than MCs ( p < .05). The baseline performance of the TX group was also worse than that of MCs ( p < .05) and did not differ from that of NTXs. No signifi cant difference between TXs and MCs was observed during the follow-up testing, however. A main effect of group ( F = 4.56; p < .05; η p 2 = .12) and an interaction ( F = 3.45; p < .05; η p 2 = .09) were also observed for the Delayed recall score of the RAVLT. Regardless of the time of testing, MCs performed better than the NTX patients ( p < .05). Patients from the TX group also presented with lower scores on Delayed verbal recall prior to kidney transplantation ( p < .05), but did not differ from MCs at the follow-up.
A signifi cant interaction was also observed for delayed recall on the BVMT-R ( F = 4.20; p < .05; η p 2 = .11), with TXs being the only group that showed an increase in score over time.
For the RCF, the main group effect was revealed only for the recall condition ( F = 8.54; p < .001; η p 2 = .21). Patients from the NTX group scored lower than MCs, regardless of the time of the assessment ( p < .001). In addition, a significant interaction was revealed ( F = 10.89; p < .001; η p 2 = .25). Patients from the TX group, despite initial difference ( p < .05), did not differ from MCs during the follow-up testing. Moreover, although the baseline performance of NTXs and TXs was similar, TX patients outperformed subjects from the NTX group during the follow-up visit ( p < .01).
A group effect ( F = 3.31; p < .05; η p 2 = .09) and an interaction ( F = 8.47; p < .001; η p 2 = .20) were observed for the Finger Tapping Test (dominant-hand). Overall, NTX patients obtained lower scores than MCs. Nevertheless, despite no baseline difference between NTXs and TXs, at follow-up the TX group performed better than the NTXs ( p < .05). For a nondominant hand condition of the Finger Tapping Test a signifi cant interaction emerged ( F = 11.66; p < .001; η p 2 = .25). In contrast to the baseline performance, during the follow-up, TXs performed better than the NTXs ( p < .05).
For the TMT-A, a group effect ( F = 11.63; p < .001; η p 2 = .25) and interaction ( F = 6.03; p < .01; η p 2 = .15) emerged. Overall, TX ( p < .05) and NTX patients ( p < .001) needed more time then MCs to complete this task. Nevertheless, despite no baseline difference between TXs and NTXs, during follow-up, TXs completed the TMT-A faster than the NTX group ( p < .01). The main group effect ( F = 4.61; p < .05; η p 2 = .12) and interaction ( F = 4.77; p < .05; η p 2 = .12) were also observed for the TMT-B. Again, both NTX ( p < .05) and TX groups ( p < .09, a trend towards statistical signifi cance) needed more time than MCs to complete the task. Nevertheless, despite no initial difference between the TX and NTX groups, during the follow-up, TXs completed the TMT-B faster than NTX patients ( p < .01).
For the Digit Symbol subtest, two main effects were noted. Regardless of the assessment, both the TX ( p < .01) and NTX groups ( p < .001) performed below the level of MCs ( F = 14.45; p < .001; η p 2 = .23). Moreover, in comparison to baseline, all three groups obtained higher scores during the follow-up testing ( F = 38.51; p < .001; η p 2 = .36). This was, however, limited by a signifi cant interaction ( F = 10.34; p < .001; η p 2 = .29). Although there was no baseline difference between TXs and NTXs, during the follow-up, TXs outperformed patients from the NTX group ( p < .05).
Main group effect was also observed for the Similarities subtest ( F = 4.69; p < .05; η p 2 = .12). Patients from the NTX group scored lower than MCs, regardless of the time of the assessment ( p < .05). Additionally, a signifi cant interaction emerged ( F = 7.11; p < .01; η p 2 = .17). Patients from the TX group obtained better results than NTXs during the follow-up testing ( p < .07, a trend towards statistical signifi cance), though no baseline difference between these groups was noted. Moreover, the initial difference between the TX and the MC group ( p < .05) was no longer present during the follow-up testing.
Depression and anxiety at baseline and follow-up
A repeated-measures ANOVA was also used to assess potential changes in depression and anxiety, as measured by the HAD Scale, but no signifi cant effects or interactions emerged.
Index of improvement and its relation with baseline and intraoperative factors
From a total of 180 exploratory correlations that were performed, only 10 signifi cant associations were found. Analysis revealed a signifi cant association between the IOI for the Digit Symbol subtest and age at baseline (rho = .44; p < .05), indicating that older TX patients showed more improvement following transplantation. Better postoperative outcome on the Digit Symbol subtest was also related to higher GFR at the follow up (rho = .21; p < .05). The duration of illness was, however, inversely correlated with the IOI for a nondominant condition of the Finger Tapping Test (rho = -.47; p < .05), suggesting less improvement in patients with longer duration of CKD. In addition, less improvement in the TMT-A was observed in patients with higher BUN prior to transplantation (rho = -.44; p < .07, a trend towards significance) and lower postoperative GFR (rho = .28; p < .05). The IOI for delayed recall of RAVLT was positively correlated with baseline serum creatinine (rho = .57; p < .05) and postoperative GFR (rho = .62; p < .05). Additionally, the IOI for delayed recall of RAVLT was inversely associated with the duration of cold organ ischemia (rho = -.66; p < .05). Hence, the shorter the cold kidney ischemia and the higher the postoperative GFR, the better the auditory delayed recall after receiving a kidney transplant. Cold organ ischemia was also correlated with the IOI for delayed recall of BVMT-R (rho = -.61; p < .05). In addition, the IOI for the TMT-B was inversely associated with baseline albumin level (rho = -.59; p < .05), indicating more improvement in patients with less albumin prior to transplantation.
DISCUSSION
The main purpose of this study was to assess the early effects of kidney transplant on cognition in adequately dialyzed patients with ESRD. Overall, our results demonstrate that a successful kidney transplant leads to a signifi cant improvement of performance in cognitive domains typically impaired in ESRD (see Pliskin et al., 2001 ) . Specifi cally, individuals who received kidney graft had improved performance on measures of psychomotor speed, visual planning, retrieval of learnt material, and abstract thinking. Additionally, the cognitive performance of adequately dialyzed patients without kidney transplant, although often below that of matched controls, remained relatively stable over time.
The fi nding that cognitive performance in adult patients with ESRD improves following kidney transplant confi rms previous research indicating a positive effect of kidney transplantation on cognitive performance (Griva et al., 2004 (Griva et al., , 2006 Kramer et al., 1996 ; Teschan et al., 1976 Teschan et al., , 1979 . Nevertheless, the results of earlier studies were not always consistent with respect to which cognitive domain improves most after kidney transplant. In addition, most of the previous research was based on cross-sectional fi ndings, and lacked well-matched control groups, which made the interpretation of their otherwise promising fi ndings somewhat limited. In the present study, two control groups were included and all groups were assessed twice. Therefore, the improved psychomotor speed, abstract thinking, and memory after kidney transplant cannot be explained by learning effects associated with repeated administration of neuropsychological tasks, although in the Digit Symbol subtest all three groups obtained higher scores at follow-up. Moreover, all participants were tested within an approximately similar extent of time. Additionally, the follow-up assessment in patients with TX was always conducted in a relatively equal and optimally shortest postoperative time, to control for variations in timing of the cognitive testing and for the potential late adverse effects of the immunosuppressive therapy (see Wijdicks, 2001 ). Also, the improved neuropsychological performance observed in the present study could not be attributed to a change in depression and anxiety, because there was no statistically signifi cant difference in number of affective symptoms pre-to post transplantation.
Some previous studies have suggested that cognitive problems in adequately dialyzed patients may be predominantly the results of comorbid conditions of ESRD. For example, it has been demonstrated that brain and cognitive function of dialyzed patients is related to anemia, because it improves with rHuEPO treatment (Grimm et al., 1990 ; Lee et al., 2004 ; Marsh et al., 1991 ) . In addition, Pliskin and coworkers (1996) suggested that impaired neuropsychological function in dialyzed patients may result from poor dialysis adequacy. Nevertheless, in the present study, individuals who were previously anemic were on erythropoeitin and, thus, the level of hemoglobin in all patients was adequate (>10 g/dl). Additionally, dialysis delivery was also adequate. Therefore, it is doubtful that cognitive problems seen in our ESRDs were a result of depressed level of hematocrit or inadequate dialysis. Moreover, because these defi cits emerged when the neuropsychological performance of two groups of dialyzed patients was compared to that of well-matched controls without renal insuffi ciency, it is likely that defective psychomotor speed, impaired visual planning, poor memory retrieval, and impaired abstract thinking in subjects with ESRD are specifi cally related to the accumulation of toxins in the brain and/or to the adverse effects of dialysis. This hypothesis is further supported by the observation that in the present study the performance on measures of most of these functions improved shortly after kidney transplant, despite no change in the level of hemoglobin.
Nevertheless, the improvement of psychomotor speed, although signifi cant, was not absolute and the performance on the Digit Symbol or TMT in patients with kidney transplant was still below that of MCs. This observation is partly consistent with some recent fi ndings indicating that cognitive limitations may still be present in TX patients (Gelb et al., 2008 ) . In the present study, however, the failure of kidney transplant to fully reverse cognitive problems associated with ESRD and/or dialysis could have been a result of the early adverse effects of high doses of immunosuppressive therapy, as well as to a relatively short time between the surgery and the follow-up assessment. Alternatively, it is possible, though unlikely, that a tendency of controls to display a learning effect on the Digit Symbol subtest could have contributed to maintained group differences.
Our research also demonstrates that the extent of cognitive improvement following kidney transplant may be associated with some pre-, intra-, and postoperative factors. For example, the results of this study suggest that the older the patient, the more improvement in psychomotor speed can be seen after kidney transplantation. This fi nding stands, however, in contrast to recently published fi ndings suggesting less cognitive improvement in older patients with ESRD (Griva et al., 2006 ) . Indeed, it is known that younger age may positively contribute to the recovery of neuropsychological function (see Kertesz & Gold, 2003 ) . Cognitive improvement may, however, appear only in those patients who initially present with neuropsychological defi cits, and it has been recently shown that individuals with CKD aged ≥ 61 are particularly susceptible to developing cognitive impairment (Thornton, Shapiro, Deria, Gelb, & Hill, 2007 ) . Thus, in our study the positive relationship between age and the IOI could have resulted from the fact that predominantly older individuals with ESRD had developed CKD-related cognitive problems prior to transplantation. Additionally, to the best of our knowledge, this is the fi rst study indicating greater cognitive improvement following kidney transplant in patients with lower pretransplant serum albumin, higher pretransplant creatinine, and better postoperative graft function. Hence, more effective graft would then enable better removal of ESRD-related toxins and, thus, positively infl uence cognition. Nevertheless, our results also suggest that the degree of the cognitive improvement may be reduced with longer duration of CKD and with higher BUN prior to transplantation. Thus, these factors might specifi cally contribute to the impaired brain function, helping to explain why some cognitive defi cits in ESRD are not fully reversible following kidney transplant. Importantly, the correlation analyses performed in this study were exploratory and preliminary in nature. Moreover, they ranged from weak to moderate and were not consistent across all cognitive measures. Therefore, these results need to be interpreted with caution and replicated in future research.
This study was designed to determine the early effects of TX on cognition. Thus, because of the choice of time-points of our follow-up, fi rm conclusions regarding the general or late outcomes following kidney transplantation seem to be relatively limited. For example, it is possible that the early benefi cial effect of kidney transplant described in this study may continue to develop over time, along with patients continuous medical and functional recovery. On the other hand, some possible late infections and immunosuppressive therapy may signifi cantly reduce the early positive effect of TX. Additionally, because all of our patients received a cadaver transplant, we could not assess a potentially differential impact of the type of graft (donor vs. cadaver) on cognition following transplantation. Nonetheless, Griva and coworkers (2004) did not fi nd any differences in this respect. Also, a relatively small number of participants in each group could have limited the statistical power of this study. Therefore, future longitudinal studies with larger samples are warranted to investigate the impact of kidney transplant on the recovery of cognitive function in dialyzed patients with ESRD in more depth and to determine the potential modifi ers of such recovery.
